Scientific advocacy has played a crucial role in improving patient outcomes throughout history. From promoting innovative treatments to advocating for evidence-based health policies, the impact of these initiatives is undeniable.

Observational studies, often called non-interventional studies, play a crucial role in understanding real-world outcomes and the effectiveness of medical interventions.

The relationship between medical information, real-world evidence (RWE), and marketing in the pharmaceutical industry is interconnected and plays a crucial role in the development, approval, and commercialization of new treatments.

In the dynamic world of the pharmaceutical industry, effective collaboration with diverse key stakeholders is paramount to ensuring success in drug development and marketing.